Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke
Elevated plasma NPY levels in the acute phase of ischaemic stroke were associated with increased risk of poor clinical outcomes after ischaemic stroke, suggesting that plasma NPY may be a potential prognostic biomarker for ischaemic stroke.
Authors
- Yaling Lu (ORCID: https://orcid.org/0000-0002-9247-5366)
- Chongke Zhong (ORCID: https://orcid.org/0000-0003-2314-6814)
- Yonghong Zhang (ORCID: https://orcid.org/0000-0003-3011-3113)
- Jiayi Long
- Wenjing Dong
- Tan Xu (ORCID: https://orcid.org/0000-0003-3798-1247)
- Yanbo Peng (ORCID: https://orcid.org/0009-0008-7122-944X)
- Guojie Zhai (ORCID: https://orcid.org/0000-0002-4056-1385)
- Zhong Ju
Institutions
- Soochow University (CN)
- North China University of Science and Technology Affiliated Hospital (CN)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1111/ene.16548
- Citations
- 4
- Primary Topic
- Neuropeptides and Animal Physiology
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- National Natural Science Foundation of China
- Ministry of Education, India
- Soochow University
- Priority Academic Program Development of Jiangsu Higher Education Institutions